November 25, 2024 at 10:37 am

Cassava Sciences’ Stock Craters 84% as Alzheimer’s Drug Trial Hits a Wall

Cassava Sciences (NASDAQ: SAVA) shares fell sharply on Monday, dropping 84% following the release of Phase 3 trial results for its Alzheimer’s drug, Simufilam. The trial, part of the ReThink-ALZ study, failed to meet its co-primary endpoints, showing no statistically significant improvement in cognitive or functional decline compared to a placebo after 52 weeks of… [Read More]
November 25, 2024 at 9:14 am

Stocks making the biggest moves premarket: Robinhoood, Bath & Body Works, MicroStrategy, Macy’s and more

Here’s a brief catch-up on some companies that are creating waves in premarket trading: Bath & Body Works saw a significant boost in their shares, with a 16% increase following a successful third-quarter earnings report. The company managed to edge out Wall Street prediction, pulling in revenue of $1.61 billion, surpassing the expected $1.58 billion…. [Read More]
November 22, 2024 at 1:41 pm

Biotech Meets Bitcoin: Anixa Biosciences Embraces Cryptocurrency to Bolster Treasury Strategy

Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company advancing cancer treatments and prevention, announced its Board of Directors has approved the purchase of Bitcoin as a treasury reserve asset. This decision aims to diversify the company’s treasury holdings and leverage Bitcoin’s potential as a long-term inflation-resistant asset. Following the announcement, Anixa’s stock saw a pre-market… [Read More]
November 22, 2024 at 12:07 pm

AI Moves: Anthropic Secures $4 Billion Investment from Amazon, Deepening Collaboration with AWS

Anthropic, a key competitor to OpenAI, has raised an additional $4 billion from Amazon (AMZN), cementing a strategic partnership that designates Amazon Web Services (AWS) as the primary platform for training Anthropic’s flagship generative AI models. The collaboration extends to AWS’s Annapurna Labs, where the two companies are working to develop next-generation Trainium chips, custom-built… [Read More]
November 22, 2024 at 9:48 am

Experiencing glitches – Reddit, the well-known discussion forum had to endure its second significant shutdown within a span of 48 hours

Uncertainty is sweeping among Reddit (NYSE:RDDT) stock traders as Advance Magazine Publishers, a major shareholder in Reddit, plans to liquidate up to $1.2 billion of its Reddit stock portfolio. This move could potentially drive down the price of Reddit shares. Despite the looming concerns, bullish investors see potential in this scenario, ready to embrace the… [Read More]
November 22, 2024 at 8:45 am

Stocks making the biggest moves premarket: Gap, NetApp, Intuit and more

Here’s a quick glimpse of companies making news in premarket trading: Intuit – The financial software company’s stock dipped roughly 3% following second-quarter earnings guidance that fell short of analyst predictions. Intuit projects earning between $2.55 and $2.61 per share for the current quarter, while analyst expectations from FactSet were set for a profit of… [Read More]
November 21, 2024 at 3:02 pm

What’s Behind the Sudden Surge in Snowflake (SNOW) Shares Today?

Data warehouse-as-a-service provider, Snowflake (NYSE:SNOW), saw a significant rise in its shares by 32.4% following the announcement of a promising Q3 for fiscal year 2025. The company’s revenue not only met but exceeded anticipated predictions, maintaining a steady net revenue retention rate. Snowflake’s success can be attributed to its focus on streamlining data workflows and… [Read More]
November 21, 2024 at 3:00 pm

Marijuana Milestone: FDA Approves Trial to Assess Smoked Medical Cannabis to Treat PTSD For Veterans

The U.S. Food and Drug Administration (FDA) has approved a significant clinical trial to assess the effectiveness of smoked medical marijuana in treating post-traumatic stress disorder (PTSD) among military veterans. This approval marks a pivotal step in exploring cannabis as a potential therapeutic option for PTSD, a condition that affects many veterans. The study is led by… [Read More]
November 21, 2024 at 12:50 pm

Matt Gaetz Withdraws from Attorney General Consideration

Former Rep. Matt Gaetz (R-Fla.) announced Thursday that he is withdrawing his name from consideration for President-elect Donald Trump’s nomination as attorney general. In a statement posted on X, Gaetz expressed gratitude for the support he received but cited concerns that his confirmation process was becoming a distraction to the Trump transition team. Gaetz emphasized… [Read More]
November 21, 2024 at 12:21 pm

All Aboard The AI Train: NVIDIA CEO States “The Age of Generative AI Is In Full Steam” in Record Q3 Report

The third quarter was another record quarter for NVIDIA (NVDA), with revenue of $35.1Bn, up 17% sequentially and 94% year-over-year (y/y). All market platforms posted strong sequential and y/y growth, driven by the adoption of NVIDIA’s accelerated computing and AI. In the data center segment, revenue reached a record $30.8Bn, up 17% sequentially and 112%… [Read More]
November 21, 2024 at 11:41 am

Cerence Bets Big on Generative AI, Stock Skyrockets 80% on 2025 Profitability Vision

Cerence Inc. (NASDAQ: CRNC), a leader in automotive artificial intelligence, announced a major strategic pivot towards generative AI during its Q4 2024 earnings call. The company aims to achieve profitability by fiscal year 2025, under the leadership of recently appointed CEO Brian Krzanich. In Q4, Cerence exceeded revenue guidance, reporting $54.8 million, with an adjusted… [Read More]
November 21, 2024 at 10:51 am

Lipella Pharmaceuticals Completes Dosing of First Cohort in Phase 2a Trial of LP-310; Top-Line Data Expected by Year-End

Today the clinical-stage biotechnology company focused on innovative therapies for serious diseases with significant unmet needs, Lipella Pharmaceuticals Inc. (LIPO) announced the completion of dosing for the first cohort in its multi-center Phase 2a clinical trial of LP-310, a liposomal-tacrolimus oral rinse being developed for the treatment of Oral Lichen Planus (OLP). First Dosing of… [Read More]